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Biological monitoring (biomonitoring) can
integrate total exposure to a chemical from all
potential sources (i.e., air, soil, water, and food
residues) and exposure routes (i.e., inhalation,
oral, and dermal), thereby offering one of the
best approaches for assessing human dosime-
try. Hence, the primary strength of biomoni-
toring is the ability to measure an internal
dose for a given chemical (Gil and Pla 2001)
that can then be used to determine risk from
exposure to these agents (Christensen 1995;
Friberg and Elinder 1993). Weis et al. (2005)
recently noted that current epidemiology
study designs are seriously hampered because
of their inability to make definitive associa-
tions between chemical exposures and disease.
However, the authors suggested that the
integration of well-designed biomonitoring
components within the framework of an epi-
demiologic evaluation offers the greatest
potential to positively impact the public
health strategy as it relates to the identiﬁcation
of important environmental health issues.
The greatest impediment to conducting
epidemiology studies is the lack of accurate
and quantitative technologies for measuring
exposure at the point of human contact and
within the organism (Weis et al. 2005). To
address these limitations, microanalytical-
based sensors are needed that are ﬁeld deploy-
able and can be used to both identify and
quantify a broad range of biomarkers associ-
ated with chemical exposures (Timchalk et al.
2004; Weis et al. 2005). As reviewed by Weis
et al. (2005), these sensor platforms offer
great promise because they have the potential
to provide a rapid, accurate, and quantitative
detection of exposure at the level of the indi-
vidual. Therefore, they effectively couple
environmental and personal exposure assess-
ments to a broad range of chemical agents in
a quantifiable and meaningful way that will
enhance the design and interpretation of
epidemiology studies.
Among toxic heavy metals, lead continues
to be one of the most problematic. Despite
considerable efforts to identify and eliminate
Pb exposure sources, this metal still remains a
signiﬁcant health concern [Banks et al. 1997;
Grigg 2004; Juberg et al. 1997; U.S. Centers
for Disease Control and Prevention (CDC)
2000] and the guidelines for potential health
effects are linked directly to measured blood
Pb levels (Jakubowski and Trzcinka-Ochocka
2005). Since the 1960s the CDC has gradu-
ally reduced the blood Pb intervention level
from 60 µg/dL to the current intervention
level of 10 µg/dL (established in 1991) for
children. However, Gilbert and Weiss (2006)
suggest that further lowering of the action
level to 2 µg/dL is warranted because of evi-
dence suggesting intellectual impairment in
children with blood Pb levels ≤ 10 µg/dL
(Canﬁeld et al. 2003). It is interesting to note
that the CDC Surveillance Summaries (CDC
2003) published from 1997 to 2001 suggest
that children’s blood Pb levels in the United
States continue to decline; however, thou-
sands of children still have elevated levels
(≥ 10 µg/dL). In addition, Pb exposure in
children from many developing industrial
countries far exceeds current U.S. guidelines
such that Pb is still a signiﬁcant world health
concern (Blaha et al. 1996; Cikrt et al. 1997;
Manay et al. 1999; Romieu et al. 1997). In
this context, it is reasonable to anticipate that
any further lowering of the blood Pb action
levels will substantially increase the number
of children at or above the intervention level.
Biomonitoring of Pb in humans repre-
sents an individual’s current body burden,
which is a function of recent and past expo-
sures (Barbosa et al. 2005). Because Pb is
sequestered in bone and has a relatively long
residence time, steady-state concentrations of
Pb in whole blood are currently used to
determine total Pb body burden (Beck 1992).
Although blood Pb remains the biomonitor-
ing method of choice, a clear statistical corre-
lation between blood Pb and adverse health
outcomes has not always been strong
(Barbosa et al. 2005). In this regard, Hu et al.
(1998) suggested that blood Pb may not be a
sufficiently sensitive biomarker, particularly
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To support the development and implementation of biological monitoring programs, we need
quantitative technologies for measuring xenobiotic exposure. Microanalytical based sensors that
work with complex biomatrices such as blood, urine, or saliva are being developed and validated
and will improve our ability to make deﬁnitive associations between chemical exposures and dis-
ease. Among toxic metals, lead continues to be one of the most problematic. Despite considerable
efforts to identify and eliminate Pb exposure sources, this metal remains a signiﬁcant health con-
cern, particularly for young children. Ongoing research focuses on the development of portable
metal analyzers that have many advantages over current available technologies, thus potentially rep-
resenting the next generation of toxic metal analyzers. In this article, we highlight the development
and validation of two classes of metal analyzers for the voltammetric detection of Pb, including:
a) an analyzer based on flow injection analysis and anodic stripping voltammetry at a mercury-
film electrode, and b) Hg-free metal analyzers employing adsorptive stripping voltammetry and
novel nanostructure materials that include the self-assembled monolayers on mesoporous supports
and carbon nanotubes. These sensors have been optimized to detect Pb in urine, blood, and saliva
as accurately as the state-of-the-art inductively coupled plasma-mass spectrometry with high repro-
ducibility, and sensitivity allows. These improved and portable analytical sensor platforms will
facilitate our ability to conduct biological monitoring programs to understand the relationship
between chemical exposure assessment and disease outcomes. Key words: biomonitoring, dosimetry
technology, electrochemical sensors, exposure assessment, lead (Pb). Environ Health Perspect
115:1683–1690 (2007). doi:10.1289/ehp.10190 available via http://dx.doi.org/ [Online
21 September 2007]in light of the in vivo dynamics of Pb tissue
redistribution. Consequently, there is sub-
stantial interest in identifying alternative Pb
biomarker matrices such as plasma/serum,
saliva, bone, teeth, feces, and urine (Barbosa
et al. 2005), which might provide a better
correlation with adverse health outcomes.
In this article we provide an overview of
ongoing research focused on the development
and validation of differing classes of portable
electrochemical-based metal analyzers that
have the potential to become the next genera-
tion of toxic metal analyzers. An important
component of the overall research effort has
been the optimization of the sensor systems to
work with complex biomatrices such as
blood, urine, or saliva. Validation of these
sensor platforms for use in biomonitoring is
particularly important in developing a person-
alized exposure assessment strategy, as sug-
gested by Weis et al. (2005), that may
improve our ability to make deﬁnitive associa-
tions between chemical exposures and disease.
Pharmacokinetics of Pb
Lead is a bone-seeking element that has a very
long residence time (i.e., months to years) in
the human body. In children (most at-risk
population) the oral route of exposure predom-
inates and Pb absorption within the gastroin-
testinal tract is as high as 40–50% (Bellinger
2004; Erickson and Thompson 2005). Within
the blood compartment, Pb is rapidly parti-
tioned between red blood cells (RBCs) and
plasma, with RBCs accounting for 95% of the
blood Pb burden (Marcus 1985; Mobarak and
P’an 1984). Pb is then redistributed to the
bone (~ 70%) and soft tissues and is excreted
slowly with its biological half-life estimated at
10 years (Erickson and Thompson 2005;
Heath et al. 2003).
Although blood measurements represent
the most common strategy for Pb biomonitor-
ing because of the strong association between
RBCs and Pb, several studies suggest that
alternative matrices such as plasma, saliva, and
urine may be useful (Timchalk et al. 2006).
Heavy metals such as Pb are excreted into the
feces via the bile or from the blood into the
urine. Of these two excretion pathways, urine
is the preferred matrix for biomonitoring, as it
represents only absorbed Pb, whereas fecal Pb
comprises both unabsorbed as well as biliary
excreted Pb (Barbosa et al. 2005). The rate of
urinary Pb excretion is reported to be directly
proportional to the plasma Pb concentration;
hence, urinary Pb reﬂects that fraction of Pb
that has cleared from the plasma via the kid-
ney and excreted in urine (Barbosa et al. 2005;
O’Flaherty 1993, 1998). However, the appli-
cation of Pb urinary biomonitoring has been
primarily limited to longer-term occupational
biomonitoring programs and the evaluation of
the efﬁcacy of chelation therapy (Barbosa et al.
2005). Nonetheless, urinary Pb biomonitoring
does offer an alternative noninvasive approach.
Although blood Pb measurement is still
considered the most reliable indicator of
recent Pb exposure, it has also been suggested
that if reliable plasma Pb measurements can
be obtained, these measurements may offer a
better correlation with observed toxicity
(Barbosa et al. 2005). In this context, correla-
tions between labile Pb concentrations in
plasma with either saliva or urine suggest that
these matrices may offer an alternative to cur-
rent invasive biomonitoring procedures.
Challenges Associated with
Sensor Development
Biomonitoring of Pb in individuals presently
relies on collection of biological samples for
subsequent laboratory analysis by means of
standard spectroscopic techniques such as
atomic absorption spectrometry (AAS) and
inductively coupled plasma–mass spectrometry
(ICP-MS). These analytical methods are gener-
ally conducted in centralized laboratories and
require signiﬁcant labor and analytical resources,
potentially resulting in substantial delays in
obtaining results. Desirable characteristics of a
portable metal analyzer include speciﬁcity for
target metal ions, enhanced measurement fre-
quency and precision, robustness, inexpensive
to fabricate and operate, ability to be auto-
mated, and minimal regeneration of sensors.
Electrochemical detection based on stripping
voltammetry appears to be a promising tech-
nique that meets those needs (Lin et al. 1999;
Wang 1994; Wang et al. 1993a). Its high
detection sensitivity is due to the combination
of the built-in preconcentration step with pow-
erful voltammetric techniques that generate an
extremely favorable signal-to-noise ratio (S/N).
For biomonitoring of toxic metals, the
complexity of the biological matrices such as
urine, blood, and saliva often prevents success-
ful use of electrochemical sensors. Over 95% of
Pb became bound to saliva proteins within
2 min of spiking Pb into the sample (Yantasee
et al. 2005c). The binding of target metals to
proteins and macromolecules in the biological
matrices can result in a low voltammetric
response to known concentrations of the met-
als (Timchalk et al. 2001; Wang 1982).
Proteins also contribute to electrode fouling,
Yantasee et al.
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Figure 1. Various electrochemical sensors for metal detection: (A) carbon paste working electrode for
batch detection, (B) screen-printed electrode, (C) electrochemical cell, and (D) schematic of a portable
metal analyzer [10.6 in (length) × 9.7 in (width) × 6.9 in (diameter)]. Abbreviations: A, auxillary; R, reference;
W, working. Reproduced from Yantasee et al. (2005b), with permission of Elsevier.
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Dwhich results in significant signal reduction
and shortening of the electrode life time. To
overcome these issues, researchers have used
techniques such as application of ultrasound
wave during the depositions of metal ions
together with coating mercury-ﬁlm electrodes
with polymers [e.g., nafion (Kruusma et al.
2004; West et al. 2002)], yet large dilution of
the samples is still required. Another approach
involves using internal standards [e.g., indium
(Liu et al. 1997) and thallium (Yang et al.
2005)] to compensate for the biological matrix
effect on the metal analysis. However, this
often increases the measurement complexity.
Other approaches involve enzyme-based
biosensors [e.g., urease (Rodriguez et al. 2004),
oxidase (Gayet et al. 1993), and dehydrogenase
(Fennouh et al. 1998)], which detect metal
ions (e.g., Hg, Pb, zinc, copper, cadmium, sil-
ver) by relying on their inhibition of enzymatic
reactions. However, the biosensors have mod-
est sensitivity (e.g., in high parts per billion or
parts per million levels). To become commer-
cially viable, biosensor design must overcome
issues including detection interference from
many components in the sample matrices, lim-
ited shelf-life of the biorecognition compo-
nents, relatively high development costs, and
the complexity of the field-deployable assay
formats (Rogers and Mascini 2006)
Sensor Development Strategies
In our laboratory, releasing Pb from the pro-
teins and minimizing electrode fouling in
urine (Yantasee et al. 2007), blood (Yantasee
et al. 2007), and saliva (Yantasee et al. 2005c)
have been accomplished with the combination
of appropriate sample pretreatment and the
optimal configurations and operation of the
sensors. The approaches are discussed herein.
For the voltammetric detection of Pb, two
classes of metal analyzers have been developed
in our laboratory: a) a metal analyzer based
on flow injection analysis (FIA) and anodic
stripping voltammetry (ASV) at a Hg-film
electrode (Yantasee et al. 2005c, 2007) and
b) Hg-free metal analyzers employing novel
nanostructure materials, which include the
self-assembled monolayers on mesoporous
supports (SAMMS) (Yantasee et al. 2005b)
and composite of SAMMS and carbon nan-
otubes (CNTs). Figure 1 presents the sensor
platforms being investigated, including a) car-
bon paste electrode (CPE) for batch measure-
ments, b) disposable screen-printed electrode
(SPE) for low-cost and ﬁeld-screening meas-
urements, and c) electrochemical cell that is
the major component of d) the programmable
portable metal analyzer. Their uses are
reviewed in the sections that follow.
Portable Metal Analyzer Based
on FIA/ASV at a Hg-Film
Electrode
To minimize electrode fouling by proteins,
we hypothesize that the turbulent ﬂowing of
the samples that are appropriately pretreated
onto the electrode surface can prevent the
adsorption of organic species on the sensor
surface. For that purpose, FIA has been
employed in conjunction with ASV technique
for successful measurements of Pb in saliva,
blood, and urine. The schematic of the
microelectrochemical cell, based on a wall-jet
(ﬂow-onto) design, is presented in Figure 1C.
The FIA system is similar to the sequential
injection analysis (SIA) system shown in
Figure 1D except that a computer-controlled
micropump delivered the carrier passing the
two-way injection valve where an exact vol-
ume of the sample was then injected. Typical
operating conditions of this metal analyzer
and the sample preparation protocol are sum-
marized in Table 1.
Figure 2 shows that Pb spiked either
before or after protein removal from the blood
by ultrafiltration yielded similar responses,
which were also similar to Pb samples contain-
ing no blood. This suggests that the pretreat-
ment protocol as in Table 1 was effective in
freeing Pb from the proteins into the ultraﬁl-
trate. In addition to releasing Pb from the pro-
teins, the acid (0.5 M HCl) also helped
minimize the adsorption of residual organic
species (< 5,000 Da) on the electrode surface.
In addition to the turbulent flow of the
samples over the electrode surface and the
acidity of the samples, cleaning of the elec-
trode at a positive potential (0.6 V for 90 sec)
in the carrier solution also removed the resid-
ual proteins along with Hg film and Pb,
hence minimizing fouling of the electrode. As
a result, the microanalyzer yielded excellent
reproducibility (in terms of relative standard
deviation; %RSD) for Pb measurements in
both blood (Figure 2) and urine samples
(Figure 3). Speciﬁcally, in samples containing
10 vol% of blood, the %RSD of 10 consecu-
tive measurements of 10 ppb Pb was 2.4
(Table 2), which was better than the 5%
reported for the ICP-MS blood Pb analysis
(Schutz et al. 1996). There was also no matrix
effect for the analysis of the samples contain-
ing 50% saliva, 10% urine, and 10% blood,
thus the calibration curve can be constructed
in pure medium and used to calculate Pb
from any sample type and donor. Although
the matrix effect was apparent in samples con-
taining 50% urine, the %RSD of 7 consecu-
tive measurements of 10 ppb Pb was 4.9
(Table 2), suggesting that there was no elec-
trode fouling at this high urine content.
Other figures of merits [linear calibration
parameters and lower detection limits (LDL)]
of FIA/ASV at Hg-film electrodes are also
summarized in Table 2 along with those from
other types of metal analyzers that are dis-
cussed in the following section.
The linear calibration ranges measured
from this metal analyzer as shown in Table 2
are highly relevant to the biomonitoring of Pb
in individuals resulting from occupational and
environmental exposures. Table 3 summarizes
the Pb concentrations measured by ICP-MS
and the microanalyzer in saliva, urine, and
blood that were collected from rats and were
spiked in vitro with Pb. The average values and
errors were highly comparable between both
methods, suggesting that the microanalyzer can
be used effectively for on-site biomonitoring of
Pb in lieu of the in-laboratory ICP-MS.
Measurement of Pb, Cd, and
Cu with FIA/ASV at a Hg-Film
Electrode
The microanalyzer has versatility in detecting
other metals in addition to Pb. Figure 4
shows linear calibration curves of Cd and Pb
Electrochemical sensors biomonitoring for lead
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Table 1. Typical operating conditions of Pb sensors based on Hg-film electrodes and SAMMS-based
electrodes.
Parameter Condition
Flow system FIA/ASV at Hg-ﬁlm electrode
Sample preparation a) Pb-spiked samples containing 10–50 vol% urine, 10 vol% bood, or 50 vol% saliva; b) 10-min 
incubation; c) acidiﬁed to 1 M HCl; and d) ﬁltered through 5,000 NMWL cut-off ultraﬁlters
Sample volume 60 µL per measurement
Carrier  5 ppm Hg/0.5 M HCl
Flow rate 1 µL/sec
Preconcentration –1.0 V, 110 sec
Detection by SWV Scan from –0.75 V to –0.45 V
Electrode precondition 0.6 V, 90 sec in carrier
Batch measurements SAMMS-based electrodes
SAMMS 5–10 wt% of SH-, AcPhos-, or IDAA-SAMMS
Conductive matrix Cabon paste, graphite ink, or carbon nanotube paste
Samples Pb in DI water, groundwater, or samples contained 25% rat urine
Sample volume 8 mL waters or 0.5 mL of urine samples
Preconcentration 2–5 min in stirred solutions at open circuit
Electrolysis –0.8 V to –1 V for 60 sec in 0.3–0.5 M HNO3 or HCl
Detection by SWV Scan from –0.7 V to –0.35 V
Electrode cleaning Often not required
Abbreviations: AcPhos, acetamide phosphonic acid; DI, deionized; IDAA, iminodiacetic acid; SWV, square-wave stripping
voltammetry.measured in single component Pb and Cd
solutions and a multicomponent Pb–Cd solu-
tion. The Pb and Cd signals were preserved
when they were detected together compared
with when they were detected separately. This
suggests that the microanalyzer could simulta-
neously detect both Cd and Pb without losing
the detection sensitivity. With the same ana-
lyzer, Cu detection has also been accomplished
as shown in Figure 5. Note that the calibration
curve was extended to at least 500 µg/L of Cu
to be relevant to blood Cu concentrations,
which are normally in parts per million levels.
The large linear range from 0 to 500 µg/L of
Cu suggests that the sensor surface is not easily
saturated by metal ion accumulation.
Hg-Free, SAMMS-Based Metal
Analyzers
Unlike conventional Hg-based sensors, the
metal microanalyzer mentioned above
required extremely small quantity of Hg (e.g.,
1 µg of Hg per measurement). However, hav-
ing considered the toxicity of Hg which may
lead to future regulation of Hg use in sensors,
we have developed new classes of metal sen-
sors that are Hg-free, yet retain the sensitivity
of the Hg-based sensors. Instead of using Hg
to preconcentrate Pb, highly sorbent materials
developed at Pacific Northwest National
Laboratory (PNNL), the self-assembled mono-
layer on mesoporous supports (SAMMS), have
been used. SAMMS materials are hybrid of
ordered mesoporous silica (Figures 6A–C)
and organic moieties (Figure 6D), which have
been tailored to be speciﬁc for the sorption of
metal ions (e.g., soft metal cations, anions,
lanthanides, and actinides). SAMMS possess
all the desired characteristics for metal ion
preconcentration at an electrode surface,
including a) high selectivity for target metals,
b) high loading capacity, c) fast sorption
kinetics, d) excellent stability because of the
covalent bonding between organic molecules
and silica substrate and cross-linking of the
silane linkages, and e) the ability to be regen-
erated. Because of their high binding afﬁnity
for Pb, three SAMMS materials functional-
ized with thiol (SH), acetamide phosphonic
acid (AcPhos), and iminodiacetic acid
(IDAA) (Figure 6D) have been investigated in
our laboratory for the preconcentration of Pb.
To construct a working electrode, SAMMS
have been used in the mixture of SAMMS–
carbon paste, SAMMS–graphite ink, or
SAMMS–CNT paste. These working elec-
trodes have then been used in batch measure-
ments (Figure 1A), a portable metal analyzer
based on sequential injection analysis/adsorp-
tive stripping voltammetric analysis [SIA/
adsorptive stripping voltammetry (AdSV)]
(Figure 1D), and in disposable sensors for
rapid screening of Pb (Figure 1B).
SAMMS–Carbon Paste
Electrodes
SAMMS–carbon paste electrodes (CPEs) were
typically constructed by mixing SAMMS pow-
der with carbon paste (graphite powder plus
mineral oil) to obtain 5–10 wt% SAMMS
consistency. AdSV at SAMMS–CPEs involved
a two-step process: a preconcentration step at
the open circuit, followed by a medium
exchange to a pure electrolyte solution for the
voltammetric quantiﬁcation. During the pre-
concentration step (2–5 min in a stirred sam-
ple), Pb(II) was accumulated on SAMMS,
which was immobilized on the carbon paste by
complexation chemistry.This technique allows
the preconcentration of metal ions without
electrolyte, applied potential, or degassing of
the solution. Because SAMMS is an electronic
insulator, to be detected sensitively, Pb bound
to SAMMS must be ﬁrst released to the con-
ductive matrix. Thus, in the electrolysis step,
accumulated Pb2+ was desorbed in an acidic
medium (0.3–0.5 M HCl or HNO3) and
simultaneously electrolyzed by applying a
negative potential (–0.9 V) for about 60 sec
to convert metal ion (Pb2+) to elemental
metal Pb0. In the detection step, the elemen-
tal metal Pb0 was subsequently stripped by
square-wave stripping voltammetry (SWV)
technique (e.g., scanning from –0.8 to
–0.3 V) to yield a Pb anodic peak at about
–0.4 to –0.6 V. After the stripping step,
cleaning often was not required, as in
0.3–0.5 M acid, Pb that was stripped out did
not readsorb onto the SAMMS.
Batch measurements. For batch Pb meas-
urements, SH–SAMMS–CPE was packed
into one end of a rod electrode (Figure 1A).
The synthesis of SH–SAMMS has been
described elsewhere (Feng et al. 1997).
SH–SAMMS has a very high afﬁnity for Hg,
Ag, gold, Cu, Cd, and Pb. When SH–SAMMS
sensors are used to evaluate Pb in complex
groundwater, the sensors can readily detect
Pb without significant sample pretreatment
other than adjusting the sample pH to 6.5.
The detection limits, linear range, and %RSD
of Pb in groundwater are summarized in
Table 2. The sensor has a detection limit of
2 ppb Pb, which is better than the U.S.
Environmental Protection Agency (EPA)
action level for Pb (15 µg/L) in public drink-
ing water supplies (EPA 2007).
Automated metal analyzer based on
SIA/AdSV. To develop the next-generation
prototype analyzer, we have integrated a SIA
with the SAMMS–CPE employing AdSV.
Figure 1D illustrates the SIA system that
included an electrochemical flow cell
Yantasee et al.
1686 VOLUME 115 | NUMBER 12 | December 2007 • Environmental Health Perspectives
Figure 2. Pb signals as a function of Pb concentrations in solution without blood
and with blood samples prepared by spiking Pb before and after proteins are
removed; inset shows the corresponding voltammograms of Pb in 10-vol% blood
sample. Reproduced from Yantasee et al. (2007), with permission of Springer.
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0 5 10 15 20 25
C
u
r
r
e
n
t
 
(
μ
A
)
Pb concentration (ppb)
Without blood
Before protein removal
After protein removal
–0.50 –0.65
0.1 μA
V
Figure 3. Pb signals as a function of Pb concentrations in samples with 0, 10, and
50 vol% of urine; inset shows the corresponding Pb voltammograms in 50%-urine
samples. Reproduced from Yantasee et al. (2007), with permission of Springer.
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30 40 50 60(Figure 1C). Inside the cell, the working elec-
trode consisted of AcPhos–SAMMS/carbon
paste material. The synthesis protocol and
characterization of AcPhos–SAMMS were
published elsewhere (Birnbaum et al. 2002;
Yantasee et al. 2003). All measurement steps
were automated, which allows for the inter-
changing of ﬂuids automatically and without
interrupting the operation. After a 2-min pre-
concentration period, the %RSD for the
response to solutions of 10 ppb Pb was 2.5%.
Such extremely low %RSD was primarily
attributed to automation of the analyzer,
thereby avoiding human error and batch-to-
batch variation. Other figures of merit are
summarized in Table 2.
Ionic species can interfere with the
voltammetric detection of Pb+2 if it can out-
compete Pb+2 for the binding sites on
SAMMS during the preconcentration step.
From batch adsorption experiments (Yantasee
et al. 2003), AcPhos–SAMMS had an afﬁnity
for metal ions in decreasing order as follows:
Pb2+ > Cu2+ > Mn2+ > Cd2+ > Zn2+ > Co2+ >
Ni2+ ~ Ca2+ >> Na+. Based on the affinity
series, calcium, Zn, nickel, cobalt, and man-
ganese could not complete with Pb for the
binding sites. This corresponds to our previ-
ous article (Yantasee et al. 2005b) that these
metal ions did not interfere with Pb signals
even when they were present at much higher
molar concentrations (e.g., 100-fold for Ca,
70-fold for Zn, Ni, Co, and 10-fold of Mn).
The sensor was also robust and reliable in the
SIA system, and the analyzer can be auto-
mated and remotely controlled.
SAMMS–Graphite Ink-Modiﬁed
Disposable Sensors
Disposable sensors for the assay of toxic metal
ions are gaining popularity because of their
low costs, simplicity, and ease of use. Of all
the disposable sensors, screen-printed carbon
electrodes (SPCEs) coupled with stripping
voltammetric techniques have been increas-
ingly investigated. Most screen-printed elec-
trodes for the sensitive assay of metal ions
have been based on Hg ﬁlm (Desmond et al.
1998; Liu et al. 1997; Wang and Baomin
1992; Wang et al. 1993b; Yang et al. 2005),
or Hg oxide particles (Choi et al. 2001) as the
modiﬁer for the working electrodes. Hg-free
SPEs have been developed by employing gold
(Masawat et al. 2003), silver (Zen et al.
2002), bare carbon electrodes (Honeychurch
et al. 2002), or by modifying electrodes with
drop coating of chemical such as 1-(2-pyridy-
lazo)-2-naphthol (Honeychurch et al. 2001a)
or calixarene (Honeychurch et al. 2001b).
However, the sensitivity, reliability, and cost
competitiveness of such electrodes have yet to
reach those of the Hg-based electrodes. To
create Hg-free disposable sensors, we have
modified the screen-printed carbon sensors
with a mixture of conductive ink and 10% by
weight of AcPhos–SAMMS. The screen-
printed sensor (Figure 1B) consisted of three
built-in electrodes on a 0.5-mm-thick plastic
substrate: screen-printed carbon as working
and counter electrodes, and Ag–Ag chloride
electrode as the reference electrode. The
screen-printed sensors were electronically con-
nected to a hand-held potentiostat for the
voltammetric analysis of Cd, Pb, and Cu as
shown in Figure 7 (Yantasee et al. 2005a).
Other figures of merit are presented in
Table 2. Because of the strong covalent bond-
ing and cross-linking of the functional groups
Electrochemical sensors biomonitoring for lead
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Table 2. Summary of ﬁgures of merit of various analyzers for the detection of Pb.
Linear slope Data range
Sensor type Electrode speciﬁcations Conditions  (µA/ppb Pb) (ppb Pb) R2 Reference
FIA/AdSV Hg ﬁlm on glassy electrode Without urine 0.030 0–50 0.996 Yantasee et al. 2007
With 10 vol% urine 0.032 0–10 0.953
With 50 vol% urine 0.017 0–50 0.995
LDL = 0.44 ppb with 50% urine
%RSD = 4.9 (n = 7, 10 ppb Pb in 50 vol% urine sample)
Without blood 0.035 0–20 0.993 Yantasee et al. 2007
With 10 vol% blood,
Pb spiked before protein removal 0.033 0–20 0.999
Pb spiked after protein removal 0.035 0–20 0.991
LDL = 0.46 ppb with 10% blood
%RSD = 2.4 (n = 10, 10 ppb Pb in 10 vol% blood sample)
In DI water, but similar to samples 0.463a 0–10 0.990 Yantasee et al. 2005c
With 50 vol% saliva
LDL = 1 ppb with 50% saliva
%RSD = 5.0 (n = 7, 10 ppb Pb in 50 vol% saliva sample)
SH–SAMMS– 5 wt% SH–SAMMS– Groundwater 0.025 0–50 0.997 New results
carbon paste carbon paste LDL = 2 ppb in groundwater
%RSD = 4.8 (n = 5, 25 ppb Pb in groundwater)
IDAA–SAMMS–CNT  10 wt% IDAA–SAMMS– Sample containing 25 vol% urine 0.316 0–20 0.998 New results
CNT paste LDL = 1.0 ppb in sample with 25% urine
%RSD = 4.5 (n = 6, 10 ppb Pb in DI water)
SIA/AdSV 10 wt% AcPhos–SAMMS– DI water 0.013 0–25 0.995 Yantasee et al. 2005b
carbon paste LDL = 1 ppb in water
%RSD = 2.5 (n = 7, 10 ppb Pb in DI water)
Disposable sensors 10 wt% AcPhos–SAMMS– DI water 0.034 0–500 0.999 Yantasee et al. 2005a
graphite ink LDL = 0.91 ppb in water
%RSD = 5 (n= 6, 10 ppb Pb in DI water)
Abbreviations: DI, deionized; LDL, low density protein; NMWL, nominal molecular weight limit; nV/A, peak area, nanovolts/amp. 
aPeak area was used as signal and the unit of slope was nV/A per ppb.
Table 3. Pb concentrations in spiked saliva, urine, and blood obtained from naïve rats.
Pb concentration (ppb)a
Biological samples ICP-MS Microanalyzer Reference
Saliva 2.2 ± NAb 2.2 ± 0.1 Yantasee et al. 2005c
6.2 ± 0.2  6.1 ± 0.3
11.6 ± 1.4c 11.9 ± 0.4
Urine 13.5 ± 0.1 14.1 ± 2.0  Yantasee et al. 2007
25.9 ± NAb 23.4 ± 1.2
Blood 64.5 ± 8.0 58.0 ± 1.1 Yantasee et al. 2007
110.9 ± 2.3 114.6 ± 0.4
aData are presented as mean ± SD, all measured with duplicate (n = 2) except b(n = 1) and c(n = 4).on the mesoporous silica supports of SAMMS
before being embedded onto the screen-
printed sensors, SAMMS-based sensors can
be reused for tens of measurements with min-
imal degradation. Being able to reuse the
same screen-printed sensor many times makes
establishment of the calibration curve possible
on a single electrode and the costs more com-
petitive when compared with most disposable
sensors that only allow a single use.
SAMMS–CNT Paste Electrodes
Although SAMMS has proven to be effective
for the preconcentration of Pb at the elec-
trode surface. even in complex matrices like
groundwater, the high contents of proteins
and macromolecules in urine, blood, and
saliva still can cause the fouling of the elec-
trodes, which results in degradation of the Pb
signals. Therefore, we have reported for the
first time the development of a novel sensor
based on a composite of IDAA–SAMMS and
CNTs in order to make a Hg-free electro-
chemical sensor that will virtually have no
fouling when used with biological samples.
The benefits of SAMMS have already been
discussed, and the popularity of CNTs is
growing rapidly in the ﬁeld of electrochemical
biosensors because of their electrocatalytic
properties in the redox reactions of many
important biomolecules as well as their
unique property in reducing the electrode
fouling caused by enzymatic products
(although the antifouling mechanism is
unclear), as reviewed by our research group
and collaborator (Lin et al. 2005).
At physiologic pH of urine, Pb was associ-
ated with urinary macromolecules and could
not be accurately quantiﬁed. Thus, before sub-
jecting these macromolecules to the sensor,
urine specimens were prepared as summarized
in Table 1. Figure 8 illustrates the linear detec-
tion range of Pb in samples containing 25 vol%
urine. and the figures of merits are summa-
rized in Table 2. The SAMMS–CNT sensors
are much more sensitive than SAMMS–CPEs
for detecting Pb; the Pb signals were about
9-fold larger in both deionized (DI) water and
sample containing 25 vol% of rat urine. At the
SAMMS–CPE, the Pb signal was virtually
zero when the sample contained 25 vol% of
urine after two measurements, which was
most likely due to the electrode fouling. On
the contrary, at the SAMMS–CNT electrode,
only small signal drop occurred when the sam-
ple contained 25 vol% urine, compared with
the sample containing no urine. Evidently,
CNTs improved the sensitivity of Pb measure-
ments as well as minimized the electrode foul-
ing in rat urine. However, without IDAA–
SAMMS to preconcentrate Pb, the CNT
paste electrode could not detect a low parts
per billion level of Pb. Thus, the composite of
the two materials opens the door for a new
breed of Hg-free sensors for sensitive and
selective detection of toxic metal ions in bio-
logical matrices at environmentally and
toxicologically relevant concentrations.
Measurements of Background
Blood Pb
The portable metal analyzer (based on FIA at
Hg-ﬁlm electrode) developed in this work was
used successfully for measurements of back-
ground Pb in human blood obtained from a
commercial supplier (Golden West Biologicals,
Inc., Temecula, CA, USA). The experimental
protocol was reviewed by the PNNL Human
Subject Institutional Review Board and was
determined to be exempt, as all samples were
obtained anonymously and could not be traced
to an individual. The blood samples were
obtained from 10 individual adult males and
subject to the portable analyzer without adding
any Pb. For these samples, no information was
available concerning any known environmental
or occupational exposures to Pb. Sample pre-
treatment procedure is summarized in Table 1.
Table 4 compares Pb concentrations obtained
independently by two researchers using our
Yantasee et al.
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Figure 6. A hybrid of (A) self-assembled monolayer
and (B) ordered mesoporous silica resulting in
(C) SAMMS structure with (D) three differing organic
moieties as the monolayers. SiO2, silicon dioxide.
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Figure 4. Voltammetric responses of Cd and Pb at the microanalyzer, measured
in single component Pb and Cd solutions and a multicomponent Pb/Cd solution.
Operating conditions are described in Table 1; inset shows the corresponding
voltammograms.
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Figure 5. Voltammetric responses of Cu at the microanalyzer. Operating condi-
tions are described in Table 1; inset shows the voltammograms of 5, 10, 20, 50,
and 100 µg/L of Cu. y = 0.16x; R2 = 1.00
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20 μAportable microanalyzer and the ICP-MS. The
microanalyzer yielded background blood Pb
levels the same as those from the state-of-the-art
ICP-MS. Similar to the ICP-MS, detection of
Pb by the microanalyzer was not affected by the
sources (donors) of blood nor the chemicals
used as anticoagulants; hence the calibration
curve can be constructed in a pure medium.
Without the undesirable matrix effect of blood,
the microanalyzer can analyze samples from
universal sources as can the ICP-MS.
Conclusions
To successfully conduct environmental epi-
demiology studies, investigators need accurate
and quantitative technologies for measuring
xenobiotic exposure. Microanalytical based
sensors that work with complex biomatrices
such as blood, urine, and saliva are being
developed and validated. These sensor plat-
forms are needed to develop a personalized
exposure assessment strategy that may
improve our ability to make deﬁnitive associa-
tions between chemical exposures and disease.
For biomonitoring of Pb, two classes of
metal analyzers have been developed at
PNNL. The first class was based on flow
injection analysis and stripping voltammetry
of Pb at a Hg-film electrode. When used to
detect Pb in blood, urine, and saliva, the ana-
lyzer has many advantages: it was very reli-
able, easy to use with automation, had high
throughput (3 min per sample), and required
only simple pretreatment of the samples that
did not involve acid digestion and large sam-
ple dilution. Thus, Pb in the concentration
range of relevance for its biomonitoring can
be accurately quantified. In addition, being
miniature in size, the analyzer had economical
use of samples (e.g., ~ 60 µL per measure-
ment), making the collection of blood less
invasive (i.e., finger prick vs. blood draw),
which is particularly important when sam-
pling children. It also required less reagents
(e.g., ~ 1 µg of Hg per measurement), thus
minimizing the health concern of Hg use.
Most important, the microanalyzer can detect
Pb in urine, blood, and saliva as accurately as
the ICP-MS with high reproducibility
(%RSD < 5) and sensitivity (low density
lipoprotein < 1 ppb), yet is much more
portable, ﬁeld deployable, and less expensive
than the ICP-MS.
The second class of metal analyzers is
made Hg-free by exploiting novel nanostruc-
ture materials; a) the SAMMS developed at
PNNL for selectively and effectively precon-
centrating Pb at the electrode surface, and
b) the CNTs for minimizing electrode fouling
and increased measurement sensitivity when
used in a composite with SAMMS. Three
SAMMS materials have been used in both
batch and automated flow measurements of
Pb as well as in disposable sensors for field
screening. In addition to excellent detection
sensitivity (low parts per billion level),
SAMMS-based sensors have many advan-
tages. The Pb preconcentration is short
(2–5 min) and requires no electrolyte and
sample degassing. Because the detection step
is performed in pure acid, it has no interfer-
ence and the electrode cleaning is not
required. The sensors have long lives because
of the stability of SAMMS. An Automated
portable analyzer based on SIA/AdSV has
been developed with SAMMS–carbon paste
as the working electrode, which will be
replaced with the SAMM–CNTs for optimal
performance in biological samples.
Electrochemical sensors biomonitoring for lead
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Table 4. Detection of background blood Pb levels in blood obtained from 10 adult males.a
Pb concentration (ppb)b Percent
Donor no. Anticoagulantc ICP-MS Microanalyzerd error
1 HP 38.7 ± 0.1 36.5 ± 0.1 5.5
1 CPDA 37.9 ± 0.5 40.0 ± 1.4 5.6
1 EDTA 40.6 ± 0.0 40.4 ± 0.1 5.7
1 NaC 36.9 ± 0.1 39.0 ± 1.3 3.8
2 NaC 28.3 ± 0.7 27.2 ± 0.2 0.5
3 NaC 17.0 ± 1.0 16.6 ± 0.5 2.6
4 NaC 11.1 ± 0.4 11.6 ± 0.5 4.5
5 NaC 6.0 ± 0.0 7.8 ± 0.3 28.9
6 NaC 12.6 ± 0.5 13.1 ± 0.2 4.1
7 NaC 11.6 ± 0.6 11.7 ± 0.3 0.9
8 NaC 9.5 ± 0.3 10.0 ± 0.3 5.9
9 NaC 124.5 ± 3.8 127.8 ± 1.2 2.7
10 NaC 19.9 ± 0.5 20.6 ± 0.1 3.3
Abbreviations: CPDA, citrate, phosphate, dextrose, and adenine; EDTA, ethylenediaminetetraacetate; HP, heparin; NaC,
sodium citrate. 
aOperating conditions are described in Table 1. bResults are presented as mean ± SD, all measured with duplicates.
cBlood samples were obtained from a commercial supplier of human tissues (Golden West Biologicals, Inc., CA) and were
not prescreened for Pb exposure. dPb concentrations were calculated from Pb signals using the slope value (0.05 µA/ppb
Pb) of the calibration curve constructed with 0–20 ppb of Pb in a pure medium without adding blood (see “Pb, single”
curve of Figure 4).
Figure 7. A Pb calibration curve at a 10 wt% AcPhos–SAMMS screen-printed
sensor after 5-min preconcentration. Inset (A) shows the corresponding Pb
voltammograms; inset (B) shows the simultaneous detection of 90 ppb Cd, 18 ppb
Pb, and 18 ppb Cu. y = 0.034x; R2 = 0.999. Reproduced from Yantasee et al.
(2005a), with permission of Elsevier. 
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Figure 8. Calibration curve of Pb in samples containing 25 vol% urine measured
after 5 min preconcentration at a IDAA–SAMMS–CNT paste electrode; inset
shows the corresponding Pb voltammograms. y= 0.316x; R2= 0.998.
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